| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Accelerating Drug Development Using Biomarkers: A Case Study with Sitagliptin, A Novel DPP4 Inhibitor for Type 2 Diabetes
|
Krishna, Rajesh
|
|
2008
|
10 |
2 |
p. 401-409
|
artikel
|
| 2 |
Application of the Biopharmaceutical Classification System in Clinical Drug Development—An Industrial View
|
Cook, Jack
|
|
2008
|
10 |
2 |
p. 306-310
|
artikel
|
| 3 |
Assessment of the Impact of Dosing Time on the Pharmacokinetics/Pharmacodynamics of Prednisolone
|
Xu, Jian
|
|
2008
|
10 |
2 |
p. 331-341
|
artikel
|
| 4 |
Assessment of the Impact of Dosing Time on the Pharmacokinetics/Pharmacodynamics of Prednisolone
|
Xu, Jian
|
|
2008
|
10 |
2 |
p. 432
|
artikel
|
| 5 |
Clinical Relevance of Dissolution Testing in Quality by Design
|
Dickinson, Paul A.
|
|
2008
|
10 |
2 |
p. 380-390
|
artikel
|
| 6 |
Current Industrial Practices in Assessing CYP450 Enzyme Induction: Preclinical and Clinical
|
Sinz, Michael
|
|
2008
|
10 |
2 |
p. 391-400
|
artikel
|
| 7 |
Current Methods for Predicting Human Food Effect
|
Lentz, Kimberley A.
|
|
2008
|
10 |
2 |
p. 282-288
|
artikel
|
| 8 |
Development of a GC-MS Assay for the Determination of Fentanyl Pharmacokinetics in Rabbit Plasma after Sublingual Spray Delivery
|
Malkawi, Ahmad H.
|
|
2008
|
10 |
2 |
p. 261-267
|
artikel
|
| 9 |
Development, Validation, and Clinical Implementation of an Assay to Measure Total Antibody Response to Naglazyme® (Galsulfase)
|
White, Joleen T.
|
|
2008
|
10 |
2 |
p. 363-372
|
artikel
|
| 10 |
Effect of Ethanol on Opioid Drug Permeability Through Caco-2 Cell Monolayers
|
Volpe, Donna A.
|
|
2008
|
10 |
2 |
p. 360-362
|
artikel
|
| 11 |
Indolealkylamines: Biotransformations and Potential Drug–Drug Interactions
|
Yu, Ai-Ming
|
|
2008
|
10 |
2 |
p. 242-253
|
artikel
|
| 12 |
In Vitro Evaluation of Reversible and Irreversible Cytochrome P450 Inhibition: Current Status on Methodologies and their Utility for Predicting Drug–Drug Interactions
|
Fowler, Stephen
|
|
2008
|
10 |
2 |
p. 410-424
|
artikel
|
| 13 |
In Vitro Studies are Sometimes Better than Conventional Human Pharmacokinetic In Vivo Studies in Assessing Bioequivalence of Immediate-Release Solid Oral Dosage Forms
|
Polli, James E.
|
|
2008
|
10 |
2 |
p. 289-299
|
artikel
|
| 14 |
Metabolic Cleavage and Translocation Efficiency of Selected Cell Penetrating Peptides: A Comparative Study with Epithelial Cell Cultures
|
Foerg, Christina
|
|
2008
|
10 |
2 |
p. 349-359
|
artikel
|
| 15 |
Microparticles for Inhalational Delivery of Antipseudomonal Antibiotics
|
Tsifansky, Michael D.
|
|
2008
|
10 |
2 |
p. 254-260
|
artikel
|
| 16 |
Mucoadhesive Microspheres for Gastroretentive Delivery of Acyclovir: In Vitro and In Vivo Evaluation
|
Dhaliwal, Sumeet
|
|
2008
|
10 |
2 |
p. 322-330
|
artikel
|
| 17 |
Overview of the Proton-coupled MCT (SLC16A) Family of Transporters: Characterization, Function and Role in the Transport of the Drug of Abuse γ-Hydroxybutyric Acid
|
Morris, Marilyn E.
|
|
2008
|
10 |
2 |
p. 311-321
|
artikel
|
| 18 |
PEITC Induces G1 Cell Cycle Arrest on HT-29 Cells Through the Activation of p38 MAPK Signaling Pathway
|
Cheung, Ka Lung
|
|
2008
|
10 |
2 |
p. 277-281
|
artikel
|
| 19 |
Quality by Design: Concepts for ANDAs
|
Lionberger, Robert A.
|
|
2008
|
10 |
2 |
p. 268-276
|
artikel
|
| 20 |
Scientific Perspectives on Extending the Provision for Waivers of In vivo Bioavailability and Bioequivalence Studies for Drug Products Containing High Solubility-Low Permeability Drugs (BCS-Class 3)
|
Stavchansky, Salomon
|
|
2008
|
10 |
2 |
p. 300-305
|
artikel
|
| 21 |
Slow Release Formulations of Inhaled Rifampin
|
Coowanitwong, Intira
|
|
2008
|
10 |
2 |
p. 342-348
|
artikel
|
| 22 |
Summary Workshop Report: Bioequivalence, Biopharmaceutics Classification System, and Beyond
|
Polli, James E.
|
|
2008
|
10 |
2 |
p. 373-379
|
artikel
|
| 23 |
Topical Ocular Delivery of NSAIDs
|
Ahuja, Munish
|
|
2008
|
10 |
2 |
p. 229-241
|
artikel
|
| 24 |
Updated Announcement—AAPS and FDA Agreement to Build Quantitative Alzheimer’s Disease Model
|
Inchauteguiz, Peter
|
|
2008
|
10 |
2 |
p. 431
|
artikel
|
| 25 |
Use of Quantitative Pharmacology in the Development of HAE1, a High-Affinity Anti-IgE Monoclonal Antibody
|
Putnam, Wendy S.
|
|
2008
|
10 |
2 |
p. 425-430
|
artikel
|
Tijdschrift beschrijving